[Personal experience with the use of infliximab].
The personal experience on the introduction and use of infliximab in the treatment of moderate-severe psoriasis is described. Reference is made to the different difficulties and obstacles posed by the use of this medication and the measures adopted to solve them and to achieve the objective for the using infliximab. The protocol adopted is briefly summarized and an example of the therapeutic follow-up sheet is shown.
Carretero
G
G
Servicio de Dermatología, Hospital Universitario de Gran Canaria Dr. Negrín, Gran Canaria, España. gacerher@gobiernodecanarias.org
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002985:Clinical Protocols; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007275:Injections, Intravenous; D008499:Medical Records; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy*; D013997:Time Factors
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab